Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01836042 · ClinicalTrials.gov registry record
Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort
A clinical trial, sponsored by Glaukos Corporation.
- Completed
- Registry status
- 108
- Enrollment target
NCT01836042 is a clinical trial that has completed, run by Glaukos Corporation. The registered enrollment target is 108 participants.
The verdict
NCT01836042 has completed, sponsored by Glaukos Corporation.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100R/L in subjects previously enrolled in Glaukos Study GC-003.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01836042
The ClinicalTrials.gov registry entry for NCT01836042 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Glaukos Corporation, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01836042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01836042 about?
NCT01836042 is a clinical study titled "Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort". The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100R/L in subjects previously enrolled in Glaukos Study GC-003.
What is the current status of trial NCT01836042?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2013-07. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01836042?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.